Univest
Univest
  • Markets
  • 3 Export Formulation, Zinc Oxide and Footwear Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, JG Chemicals and Redtape

    • October 15, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Export Formulation, Zinc Oxide and Footwear Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, JG Chemicals and Redtape

    Lincoln Pharmaceuticals, JG Chemicals and Redtape compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Formulation Maker, Glycol Producer and Pizza Chain Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, India Glycols and Jubilant FoodWorks

    • October 15, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Formulation Maker, Glycol Producer and Pizza Chain Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, India Glycols and Jubilant FoodWorks

    Lincoln Pharmaceuticals, India Glycols and Jubilant FoodWorks compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Pharma Exporter, Boron Chemical and Basmati Rice Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Indo Borax & Chemicals and LT Foods

    • October 15, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Pharma Exporter, Boron Chemical and Basmati Rice Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Indo Borax & Chemicals and LT Foods

    Lincoln Pharmaceuticals, Indo Borax & Chemicals and LT Foods compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Contract Manufacturer, Emerging Market Generic and Device Stocks With a Strong Future Roadmap: Akums Drugs and Pharmaceuticals, Lincoln Pharmaceuticals and Poly Medicure

    • October 14, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Contract Manufacturer, Emerging Market Generic and Device Stocks With a Strong Future Roadmap: Akums Drugs and Pharmaceuticals, Lincoln Pharmaceuticals and Poly Medicure

    Akums Drugs and Pharmaceuticals, Lincoln Pharmaceuticals and Poly Medicure compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Vaccine, Formulation and Pharmacy Chain Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Lincoln Pharmaceuticals and Medplus Health Services

    • October 13, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Vaccine, Formulation and Pharmacy Chain Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Lincoln Pharmaceuticals and Medplus Health Services

    GlaxoSmithKline Pharmaceuticals, Lincoln Pharmaceuticals and Medplus Health Services compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Medicines and Lab Testing Stocks With a Strong Future Roadmap: Aurobindo Pharma, Lincoln Pharmaceuticals and Suraksha Diagnostic

    • October 12, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Medicines and Lab Testing Stocks With a Strong Future Roadmap: Aurobindo Pharma, Lincoln Pharmaceuticals and Suraksha Diagnostic

    Aurobindo Pharma, Lincoln Pharmaceuticals and Suraksha Diagnostic compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 3 Formulation and Enzyme Maker Stocks With a Strong Future Roadmap: Alkem Laboratories, Lincoln Pharmaceuticals and Advanced Enzyme Technologies

    • October 12, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Formulation and Enzyme Maker Stocks With a Strong Future Roadmap: Alkem Laboratories, Lincoln Pharmaceuticals and Advanced Enzyme Technologies

    Alkem Laboratories, Lincoln Pharmaceuticals and Advanced Enzyme Technologies compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 1
  • 2